Last reviewed: May 12, 2026
Last updated: May 12, 2026
Written by:
Jay Hastings
,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
IRF4 and Skin Cancer Risk: What Your Genotype Means for Sun Safety and Skin Health
Skin cancer is one of the most common cancers and includes basal cell carcinoma, squamous cell carcinoma, and melanoma. While lifetime risk is influenced by many factors, two of the most important are sun exposure and skin pigmentation. The IRF4 gene helps regulate pigmentation and some cellular processes in the skin, so certain genetic variants in IRF4 can change how likely a person is to develop moles and skin cancer.
This article explains how variation at a single location in IRF4 (rs12203592) relates to skin cancer risk, practical steps you can take to protect your skin, and lifestyle and diet choices that support skin health. PlexusDx does not provide medical advice. This information is educational only. Always consult your healthcare provider or a dermatologist about screening, diagnosis, or treatment options.
How IRF4 Affects Skin Cancer Risk
IRF4 plays a role in how melanocytes, the pigment producing cells in the skin, behave. Changes in IRF4 can influence pigmentation, the number and appearance of moles, and how skin cells respond to DNA damage from ultraviolet radiation. Those differences can translate into a higher or typical genetic predisposition for skin cancer. Importantly, genetics is only one piece of the picture. Sun exposure, tanning bed use, immune status, and other environmental and lifestyle factors matter greatly.
Everyday actions that reduce skin cancer risk
- Use broad spectrum sunscreen with SPF 30 or higher every day on exposed skin, and reapply every two hours or after swimming or sweating.
- Wear sun protective clothing, a wide brim hat, and UV-protective sunglasses.
- Avoid tanning beds and intentional tanning.
- Seek shade and reduce outdoor activity during peak UV hours, typically 10 AM to 4 PM.
- Perform monthly self skin checks for new or changing moles. Learn the ABCDEs of melanoma: Asymmetry, Border irregularity, Color variation, Diameter larger than 6 mm, and Evolution or change over time.
- Schedule regular skin exams with a dermatologist. Frequency depends on your risk and should be determined with your provider.
- Maintain a diet rich in colorful fruits and vegetables to ensure a variety of antioxidants and phytonutrients that support skin repair and overall health.
Diet, supplements, and tests to consider
A healthy diet supports skin resilience. Focus on vegetables, fruits, healthy fats, whole grains, and lean protein. Specific considerations include:
- Antioxidant rich foods: berries, leafy greens, tomatoes, carrots, citrus, and bell peppers supply vitamin C, carotenoids, and polyphenols that help protect skin cells.
- Healthy fats: omega 3 fatty acids from fatty fish, walnuts, chia, and flaxseed support skin barrier health and may reduce inflammation.
- Vitamin D: sun avoidance and sunscreen use can lower vitamin D production. Discuss vitamin D testing and supplementation with your healthcare provider if concerned.
- Topical skin care: use gentle cleansers and moisturizers to support barrier function. Products containing antioxidants such as vitamin C or niacinamide can be helpful for overall skin health.
- Supplements: you may discuss antioxidants or omega 3 supplements with your clinician. Any supplementation should be personalized and reviewed with your provider.
Remember, supplements and diet are complementary to sun protection and screening, not substitutes.
Genetic Interpretations for rs12203592 (IRF4)
Two effect alleles (TT) — increased risk
If you have the TT genotype for rs12203592, you carry two copies of the effect allele associated with an increased risk of developing skin cancer and moles. Variations at IRF4 may alter how melanocytes function and how genes involved in cell growth are regulated, affecting susceptibility to basal cell carcinoma, squamous cell carcinoma, and melanoma.
Practical steps
- Use broad spectrum sunscreen SPF 30 or higher every day and reapply often.
- Wear protective clothing, hats, and sunglasses when outdoors.
- Avoid tanning beds and intentional sunbathing.
- Limit exposure during peak UV hours (10 AM to 4 PM) and use shade when possible.
- Perform monthly self-exams and see a dermatologist at least annually or more often if recommended by your clinician.
- Eat a diet high in antioxidants and consider discussing vitamin D status with your healthcare provider.
- Report any rapidly changing, bleeding, or irregular moles to a dermatologist promptly.
One effect allele (CT) — likely increased risk
If you have the CT genotype for rs12203592, you carry one copy of the effect allele and may have a likely increased risk of skin cancer and moles. This variant can affect pigmentation and cellular regulation pathways in melanocytes, which can influence risk.
Practical steps
- Practice daily sun protection with SPF 30 or higher and protective clothing.
- Avoid tanning beds and prolonged direct sun exposure.
- Perform regular self skin checks and seek dermatologic evaluation for suspicious or changing lesions.
- Include antioxidant rich foods in your diet and discuss any supplements with your healthcare provider.
- Consider yearly skin exams, or more frequent follow up if you have many moles or a history of atypical lesions.
No effect alleles (CC) — typical risk related to this variant
If you have the CC genotype for rs12203592, you do not carry the T allele linked to increased susceptibility at this IRF4 location. This genotype is associated with typical risk for this particular genetic variant. However, skin cancer remains common and is strongly influenced by non genetic factors, especially UV exposure.
Practical steps
- Follow standard sun safety: daily SPF 30 or higher, protective clothing, hats, and sunglasses.
- Avoid tanning beds and seek shade during peak hours.
- Perform monthly self-examinations for new or changing moles and get routine dermatology checkups as recommended.
- Adopt a diet rich in fruits and vegetables to support skin health.
When to talk to your healthcare provider
- If you notice a mole that is changing in size, shape, color, or is symptomatic like bleeding or itching.
- If you have a family history of melanoma or multiple atypical moles.
- If you are planning significant sun exposure due to work or travel and want personalized prevention strategies.
- To discuss vitamin D testing if you are limiting sun exposure or using high sun protection regularly.
PlexusDx does not provide medical advice. This information is educational and intended to help you understand how an IRF4 variant may influence skin health and what general preventive steps can reduce risk. Always consult your healthcare provider or a board certified dermatologist for personalized medical guidance, screening schedules, and treatment decisions.
If this genetic variant is present in your PlexusDx results, the following tests and reports are commonly used to explore it further:
🧬 Genetic Tests:
🧪 Blood Tests:
📄 Genetic Report:
Frequently Asked Questions About SKIN CANCER and IRF4 rs12203592
What does the IRF4 rs12203592 genotype mean for my skin cancer risk?
The IRF4 gene helps regulate pigmentation and cellular processes in the skin, including how melanocytes respond to UV-related DNA damage. At rs12203592, carrying two effect alleles (TT) is associated with increased risk of skin cancer and moles, having one effect allele (CT) is likely increased risk, and having no effect alleles (CC) is typical risk related to this specific variant. Genetics is only part of the overall risk picture—sun exposure and other factors strongly influence your outcome.
How should I change my sun protection routine if my results show IRF4 rs12203592 (TT or CT)?
If you carry the effect allele (TT or CT), focus on consistent daily broad-spectrum sunscreen SPF 30+ and reapply every two hours or after swimming/sweating. Wear sun-protective clothing, a wide-brim hat, and UV-protective sunglasses, avoid tanning beds, and limit time outdoors during peak UV hours (typically 10 AM to 4 PM) using shade when possible. Also prioritize regular dermatologist skin exams and prompt evaluation of any suspicious or changing moles.
What lifestyle and diet steps support skin health alongside IRF4-related predisposition?
Support skin resilience with a diet rich in colorful fruits and vegetables (antioxidant-rich foods like berries, leafy greens, tomatoes, carrots, citrus, and bell peppers) and healthy fats (omega-3 sources such as fatty fish, walnuts, chia, and flaxseed). If you reduce sun exposure for prevention, ask your healthcare provider about vitamin D testing or supplementation as needed. Consider gentle topical skin care that supports your skin barrier, and remember that diet and supplements complement—never replace—sun safety and routine screening.
What tests can help me learn more about SKIN CANCER and IRF4 rs12203592?
The Longevity and Healthy Aging Genetic Test delivers over 200 genetic insights related to cellular repair, inflammation balance, metabolism, cardiometabolic health, and aging pathways. The Healthy Aging Genetic Report translates your results into personalized, actionable guidance. Your healthcare provider can also recommend targeted blood tests based on your specific pathway results and health history to complement your genetic insights with current biomarker data.
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
OSTEOPOROSIS | TNFSF11 (rs2277438)
OSTEOPOROSIS | TNFSF11 (rs2277438)